Folding proteins in fatal ways (original) (raw)

• Glenner, G. G. Amyloid deposits and amyloidosis: the β-fibrilloses (first of two parts). N. Engl. J. Med. 302, 1283–1292 (1980).
  Article CAS Google Scholar
• Glenner, G. G. Amyloid deposits and amyloidosis: the β-fibrilloses (second of two parts). N. Engl. J. Med. 302, 1333–1343 (1980).
  Article CAS Google Scholar
• Fandrich, M., Fletcher, M. A. & Dobson, C. M. Amyloid fibrils from muscle myoglobin. Nature 410, 165–166 (2001).
  Article ADS CAS Google Scholar
• Bucciantini, M. et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507–511 (2002).
  Article ADS CAS Google Scholar
• Dobson, C. M. The structural basis of protein folding and its links with human disease. Phil. Trans. R. Soc. Lond. B 356, 133–145 (2001).
  Article CAS Google Scholar
• Jarrett, J. T. & Lansbury, P. T. Seeding 'one-dimensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055–1058 (1993).
  Article CAS Google Scholar
• Perutz, M. F. & Windle, A. H. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats. Nature 412, 143–144 (2001).
  Article ADS CAS Google Scholar
• Zoghbi, H. Y. & Orr, H. T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217–247 (2000).
  Article CAS Google Scholar
• Selkoe, D. J. & Podlisny, M. B. Deciphering the genetic basis of Alzheimer's disease. Annu. Rev. Genomics Hum. Genet. 3, 67–99 (2002).
  Article CAS Google Scholar
• Hutton, M. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurology 56, S21–S25 (2001).
  Article CAS Google Scholar
• Prusiner, S. B. Neurodegenerative diseases and prions. N. Engl. J. Med. 344, 1516–1526 (2001).
  Article CAS Google Scholar
• Booth, D. R. et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787–793 (1997).
  Article ADS CAS Google Scholar
• Haezebrouck, P. et al. An equilibrium partially folded state of human lysozyme at low pH. J. Mol. Biol. 246, 382–387 (1995).
  Article CAS Google Scholar
• Radford, S. E. & Dobson, C. M. Insights into protein folding using physical techniques: studies of lysozyme and α-lactalbumin. Phil. Trans. R. Soc. Lond. B 348, 17–25 (1995).
  Article ADS CAS Google Scholar
• Riek, R. et al. NMR structure of the mouse prion protein domain PrP(121–231). Nature 382, 180–182 (1996).
  Article ADS CAS Google Scholar
• Hsia, A. Y. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl Acad. Sci. USA 96, 3228–3233 (1999).
  Article ADS CAS Google Scholar
• Mucke, L. et al. High-level neuronal expression of Aβ 1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058 (2000).
  Article CAS Google Scholar
• Naslund, J. et al. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. J. Am. Med. Assoc. 283, 1571–1577 (2000).
  Article CAS Google Scholar
• Kuo, Y.-M. et al. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077–4081 (1996).
  Article CAS Google Scholar
• Lue, L. F. et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853–862 (1999).
  Article ADS CAS Google Scholar
• Selkoe, D. J. Alzheimer's disease is a synaptic failure. Science 298, 789–791 (2002).
  Article ADS CAS Google Scholar
• Walsh, D. et al. Naturally secreted oligomers of the Alzheimer amyloid β-protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539 (2002).
  Article ADS CAS Google Scholar
• Watase, K. et al. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron 34, 905–919 (2002).
  Article CAS Google Scholar
• Auluck, P. K., Chan, H. Y., Trojanowski, J. Q., Lee, V. M. & Bonini, N. M. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865–868 (2002).
  Article ADS CAS Google Scholar
• Warrick, J. M. et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nature Genet. 23, 425–428 (1999).
  Article CAS Google Scholar
• Opal, P. & Zoghbi, H. Y. The role of chaperones in polyglutamine disease. Trends Mol. Med. 8, 232–236 (2002).
  Article CAS Google Scholar